Sanofi-Aventis India In Damage Control Mode As Local Press Errs And Says Combiflam Banned, Instead Of Comiflam
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - The Indian arm of French multinational Sanofi Aventis went into a speedy damage control mode after several vernacular newspapers incorrectly reported that one of its biggest revenue earners Combiflam (ibuprofen/paracetamol) was banned following an order of the State Drug Authorities in Rajasthan - a state in Western India - under the provisions of the Drugs & Cosmetics Act